Steven A. Lisi - Sep 26, 2024 Form 4 Insider Report for Beyond Air, Inc. (XAIR)

Role: CEO and Chairman of the Board, Director
Signature: /s/ Steven A. Lisi
Stock symbol: XAIR
Transactions as of: Sep 26, 2024
Transactions value $: $744,662
Form type: 4
Date filed: 10/1/2024, 09:27 PM
Previous filing: Aug 19, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	XAIR	Common Stock	Purchase	$745K	+1.48M	+83.29%	$0.50	3.25M	Sep 26, 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	XAIR	Pre-funded Warrants to purchase Common Stock	Purchase		+506K			506K	Sep 26, 2024	Common Stock	506K	$0.00	Direct	F1, F2, F3
transaction	XAIR	Warrants to purchase Common Stock	Purchase		+1.98M			1.98M	Sep 26, 2024	Common Stock	1.98M	$0.38	Direct	F1, F4, F5
transaction	XAIR	Warrants to purchase Common Stock	Other		+3.3M			3.3M	Sep 27, 2024	Common Stock	3.3M	$0.38	Direct	F6, F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Pursuant to a Securities Purchase Agreement (the "Agreement"), dated as of September 26, 2024, by and between Beyond Air, Inc. (the "Issuer") and Steven Lisi (the "Reporting Person"), the Reporting Person acquired in a private placement transaction 1,476,626 shares of common stock, $0.0001 par value per share (the "Common Stock"), pre-funded warrants to acquire 506,321 shares of Common Stock at an exercise price of $0.0001 per share, and common warrants to acquire 1,982,947 shares of Common Stock at an exercise price of $0.3793 per share.
F2	The pre-funded warrants will be exercisable on or after the date on which the Company obtains stockholder approval (the "Initial Exercise Date"), as further described in the Agreement and in the Issuer's Current Report on Form 8-K filed with the SEC on September 27, 2024, and shall expire when exercised in full.
F3	Each pre-funded warrant was purchased with an accompanying warrant for a purchase price of $0.5042 per pre-funded warrant and accompanying warrant.
F4	The common warrants are exercisable on or after the Initial Exercise Date and will have a term that expires five years following the Initial Exercise Date.
F5	Each common share was purchased with an accompanying warrant for a purchase price of $0.5043 per share and accompanying warrant.
F6	Pursuant to a binding term sheet dated as of September 27, 2024 in connection with a loan to the Issuer of $2,500,000, the Reporting Person acquired warrants to purchase up to 3,295,544 shares of Common Stock.
F7	The warrants issuable will be exercisable on or after the Initial Exercise Date and will expire five years following such date they are exercisable.